Disclosures: Pedro Ochoa-Allemant: Nothing to Disclose, Rebecca Hubbard: Nothing to Disclose, David Kaplan: AstraZeneca Inc: Grant/Research Support, Roche Genentech: Independent Contractor, Exact Sciences: Grant/Research Support, Glycotest: Grant/Research Support, Sirtex: Advisor, Exelixis: Advisor, AstraZeneca: Advisor, Marina Serper: Transplant Genomics: Grant/Research Support, Grifols: Grant/Research Support, Eurofins: Grant/Research Support 1066 ANALYSIS OF THE DISTRIBUTION AND SEVERITY OF LIVER FIBROSIS STAGES AMONG THE LOCAL POPULATION WITHIN THE RIO GRANDE VALLEY: IDENTIFICATION OF RISK FACTORS AND ACCURACY OF NON-INVASIVE DIAGNOSTIC TOOLS Dimple Desai Rashmee Patil 1 , 1 South Texas Research Institute Background: In the Rio Grande Valley of South Texas, a region with a high prevalence of metabolic disorders such as diabetes, obesity, and hypertension, liver fibrosis presents as a significant health challenge in the Hispanic population
No additional ions except for those corresponding to 2 were detected
I pretty much follow it as well and have gone from 195 pounds to 133 pounds
Newman and Thornley, 1996) have predominantly focused on legal-administrative frameworks but largely neglected local land-use regulations
